Drop to Gate Nasal Drops Attenuates Sepsis‐Induced Cognitive Dysfunction
Small · 2024
DOI: 10.1002/smll.202403564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Yaping Zhuang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and O…. Hauptthemen laut MEDLINE: Administration, Intranasal, Cognitive Dysfunction, Sepsis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Program of Shanghai Academic/Technology Research Leader.
Themen: Sepsis
Abstract (Originalsprache)
Nasal administration can bypass the blood‐brain barrier and directly deliver drugs to the brain, providing a non‐invasive route for central nervous system (CNS) diseases. Inspired by the appearance that a gate can block the outside world and the characteristics of the sol–gel transition can form a “gate” in the nasal cavity, a Drop to Gate nasal drop (DGND) is designed to set a gate in nose, which achieves protecting role from the influence of nasal environment. The DGND demonstrates the efficiency and application prospect of delivering drugs to the brain through the N‐to‐B. The effective concentration of single administration is increased through the hydrophobic interaction between C 8 ‐GelMA and SRT1720 (SA), and then cross‐linked under UV to form nanogel, which can respond to MMP in the inflammatory microenvironment of sepsis‐induced cognitive dysfunction. Finally, the SA/nanogel is compounded into the thermogel, which can respond to the nasal cavity temperature to form DGND in situ, increasing the residence time and delivery efficiency of drugs in the nasal cavity. In vitro, the DGND alleviates lipopolysaccharides (LPS)‐induced BV2 inflammation. In vivo, DGND effectively targets the nasal mucosa and deliver drugs to the brain, which activate Sirt1 to alleviate inflammation mediated by microglia and improve cognitive dysfunction in sepsis mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of…
- Department of Anesthesiology, Huadong Hospital Affiliated to Fudan University, No. 221 Yan'an West Road, Jing'an, Shanghai, 200040, P. R. China.
- Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Huangpu, Shanghai, 200025, P. R. China.
ORCID-Profile: Wenguo Cui
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Program of Shanghai Academic/Technology Research Leader
- "Science and Technology Innovation Action Plan" Domestic Science and Technology Cooperation Project of Shanghai
- Shanghai Municipal Health Commission Research Project (Youth)
- Huadong Hospital Excellent Project
- Program of Shanghai Academic Research Leader
Zitieren
APA
Zhuang, Y., Du, X., Yang, L., Jiang, Z., Yu, B., Gu, W., Cui, W., & Lu, H. (2024). Drop to Gate Nasal Drops Attenuates Sepsis‐Induced Cognitive Dysfunction. Small. https://doi.org/10.1002/smll.202403564
Vancouver
Zhuang Y, Du X, Yang L, Jiang Z, Yu B, Gu W, et al. Drop to Gate Nasal Drops Attenuates Sepsis‐Induced Cognitive Dysfunction. Small. 2024. doi:10.1002/smll.202403564
BibTeX
@article{Zhuang2024,
author = {Zhuang, Yaping and Du, Xiyu and Yang, Li and Jiang, Zhaoshun and Yu, Buwei and Gu, Weidong and Cui, Wenguo and Lu, Han},
title = {Drop to Gate Nasal Drops Attenuates Sepsis‐Induced Cognitive Dysfunction},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202403564}
}
EUVIMED